ATRA
Price
$8.24
Change
+$0.44 (+5.64%)
Updated
Jul 2, 04:59 PM (EDT)
Capitalization
47.27M
EDIT
Price
$2.56
Change
+$0.31 (+13.78%)
Updated
Jul 2, 04:59 PM (EDT)
Capitalization
188.35M
28 days until earnings call
Interact to see
Advertisement

ATRA vs EDIT

Header iconATRA vs EDIT Comparison
Open Charts ATRA vs EDITBanner chart's image
Atara Biotherapeutics
Price$8.24
Change+$0.44 (+5.64%)
Volume$600
Capitalization47.27M
Editas Medicine
Price$2.56
Change+$0.31 (+13.78%)
Volume$180.26K
Capitalization188.35M
ATRA vs EDIT Comparison Chart in %
Loading...
ATRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EDIT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATRA vs. EDIT commentary
Jul 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATRA is a Hold and EDIT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 03, 2025
Stock price -- (ATRA: $7.80 vs. EDIT: $2.56)
Brand notoriety: ATRA and EDIT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATRA: 36% vs. EDIT: 419%
Market capitalization -- ATRA: $47.27M vs. EDIT: $188.35M
ATRA [@Biotechnology] is valued at $47.27M. EDIT’s [@Biotechnology] market capitalization is $188.35M. The market cap for tickers in the [@Biotechnology] industry ranges from $306.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.33B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATRA’s FA Score shows that 0 FA rating(s) are green whileEDIT’s FA Score has 0 green FA rating(s).

  • ATRA’s FA Score: 0 green, 5 red.
  • EDIT’s FA Score: 0 green, 5 red.
According to our system of comparison, EDIT is a better buy in the long-term than ATRA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATRA’s TA Score shows that 3 TA indicator(s) are bullish while EDIT’s TA Score has 2 bullish TA indicator(s).

  • ATRA’s TA Score: 3 bullish, 5 bearish.
  • EDIT’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, both ATRA and EDIT are a bad buy in the short-term.

Price Growth

ATRA (@Biotechnology) experienced а -3.23% price change this week, while EDIT (@Biotechnology) price change was +16.67% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.46%. For the same industry, the average monthly price growth was +33.64%, and the average quarterly price growth was +2.14%.

Reported Earning Dates

ATRA is expected to report earnings on May 15, 2025.

EDIT is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (+1.46% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EDIT($188M) has a higher market cap than ATRA($47.3M). EDIT YTD gains are higher at: 101.181 vs. ATRA (-41.397). ATRA has higher annual earnings (EBITDA): -5.74M vs. EDIT (-244.52M). EDIT has more cash in the bank: 221M vs. ATRA (13.8M). EDIT has less debt than ATRA: EDIT (31.1M) vs ATRA (40.6M). ATRA has higher revenues than EDIT: ATRA (200M) vs EDIT (35.8M).
ATRAEDITATRA / EDIT
Capitalization47.3M188M25%
EBITDA-5.74M-244.52M2%
Gain YTD-41.397101.181-41%
P/E RatioN/AN/A-
Revenue200M35.8M559%
Total Cash13.8M221M6%
Total Debt40.6M31.1M131%
FUNDAMENTALS RATINGS
ATRA vs EDIT: Fundamental Ratings
ATRA
EDIT
OUTLOOK RATING
1..100
6970
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
38
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
5937
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

EDIT's Valuation (38) in the Biotechnology industry is somewhat better than the same rating for ATRA (74). This means that EDIT’s stock grew somewhat faster than ATRA’s over the last 12 months.

EDIT's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ATRA (100). This means that EDIT’s stock grew similarly to ATRA’s over the last 12 months.

EDIT's SMR Rating (99) in the Biotechnology industry is in the same range as ATRA (100). This means that EDIT’s stock grew similarly to ATRA’s over the last 12 months.

EDIT's Price Growth Rating (37) in the Biotechnology industry is in the same range as ATRA (59). This means that EDIT’s stock grew similarly to ATRA’s over the last 12 months.

EDIT's P/E Growth Rating (100) in the Biotechnology industry is in the same range as ATRA (100). This means that EDIT’s stock grew similarly to ATRA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATRAEDIT
RSI
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 24 days ago
82%
Bullish Trend 23 days ago
76%
Declines
ODDS (%)
Bearish Trend 10 days ago
87%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
Aroon
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
ATRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EDIT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LEGN36.290.80
+2.25%
Legend Biotech Corp
SCM14.010.07
+0.50%
STELLUS CAPITAL INVESTMENT Corp
UNH311.97N/A
N/A
Unitedhealth Group
INTG11.55N/A
N/A
Intergroup Corp
ANIP63.56-1.69
-2.59%
ANI Pharmaceuticals

ATRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATRA has been closely correlated with IKNA. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if ATRA jumps, then IKNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATRA
1D Price
Change %
ATRA100%
+1.04%
IKNA - ATRA
72%
Closely correlated
-1.49%
ABCZF - ATRA
53%
Loosely correlated
N/A
RAPT - ATRA
37%
Loosely correlated
-8.38%
PHAT - ATRA
36%
Loosely correlated
-7.72%
LENZ - ATRA
33%
Loosely correlated
+2.52%
More